Skip to main content

Table 1 General characteristics of the patients at the beginning of the study (V1)

From: Evaluation, intervention, and follow-up of patients with diabetes in a primary health care setting in Brazil: the importance of a specialized mobile consultancy

 

Variables

Group 1

Group 2

Group 3

Total

p value

Gender

Female

9 (60.0)

12 (85.7)

12 (52.2)

33 (63.5)

0.110*

 

Male

6 (40.0)

2 (14.3)

11 (47.8)

19 (36.5)

 

Age

<60 years

2 (13.3)

3 (21.4)

11 (47.8)

16 (30.8)

0.068**

 

≥60 years

13 (86.7)

11 (78.6)

12 (52.2)

36 (69.2)

 

Race

White

14 (93.3)

10 (71.5)

18 (78.3)

42 (80.8)

0.326**

 

Non white

1 (6.7)

4 (28.6)

5 (21.7)

10 (19.2)

 

Educational level

≤8 years

9 (60.0)

11 (78.6)

13 (56.5)

33 (63.4)

0.380*

 

>8 years

6 (40.0)

3 (21.4)

10 (43.5)

19 (36.6)

 

Smoking

No

14 (93.3)

14 (100.0)

23 (100)

51 (98.1)

0.557**

 

Yes

1 (6.7)

0

0

1 (1.9)

 

Alcoholism

No

13 (86.7)

14 (100.0)

23 (100)

50 (96.2)

0.148**

 

Yes

2 (13.3)

0

0

2 (3.8)

 

Physical Activity

Mild/moderate

7 (46.7)

7 (50.0)

10 (43.5)

34 (46.1)

0.927*

 

Sedentary

8 (53.3)

7 (50.0)

13 (56.5)

28 (53.9)

 

Treatment

NP

0

0

2 (8.7 %)

2 (3.8 %)

0.179**

 

OM

9 (60 %)

12 (85.7 %)

17 (74 %)

38 (73.2 %)

 
 

OM/I

6 (40.0 %)

2 (14.3 %)

4 (17.3 %)

12 (23.0 %)

 

DM duration (years)

10 (8, 23.5)

11 (3.5, 19.3)

6 (3, 11)

9 (4, 15)

0.083***

BMI

30.37 ± 6.2

30.32 ± 4.5

29.67 ± 3.9

30.05 ± 4.7

0.470***

WC

Female

102.7 ± 14.6

98.4 ± 9.6

104.62 ± 10.3

101.8 ± 11.3

0.356***

 

Male

109.4 ± 12.2

117 ± 12.0

103.1 ± 10.0

106.6 ± 11.3

0.320***

WC/HC

Female

0.94 ± 0.03

0.93 ± 0.03

0.99 ± 0.03

0.95 ± 0.04

0.001***

 

Male

0.99 ± 0.04

1.04 ± 0.04

0.99 ± 0.05

0.99 ± 0.05

0.358***

Family

No

8 (53.3)

4 (28.6)

3 (13.0)

15 (28.8)

0.027**

History (DM)

Yes

7 (46.7)

10 (71.4)

20 (87.0)

37 (71.2)

 

Complication

Low

2 (13.3)

3 (21.4)

3 (13.0)

8 (15.4)

 

Risk

Medium

3 (20.0)

6 (42.9)

11 (47.9)

20 (38.4)

0.371**

 

High

10 (66.7)

5 (35.7)

9 (39.1)

24 (46.2)

 
  1. NP non-pharmacological treatment; OM oral medications; OM/I oral medications and insulin; BMI body mass index; WC waist circumference; WC/HC waist circumference/hip circumference ratio
  2. * Chi square test
  3. ** Fisher exact test
  4. *** Kruskal–Wallis test